3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
13
Brain Neoplasms
11
Lung Neoplasms
9
Neoplasm Metastasis
8
Pancreatic Neoplasms
4
Breast Neoplasms
4
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Small Cell Lung Carcinoma
2
Meningioma
2
Melanoma
2
Urogenital Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Oligometastatic Prostate Cancer
1
NSCLC
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Transitional Cell
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Radiosurgery
×
30 days
×
Clear all
No trials found.